Target
Mu-type opioid receptor
Ligand
BDBM464586
Substrate
n/a
Meas. Tech.
Receptor Binding Assay
Ki
16.0±n/a nM
Citation
 Kuehnert, SKoenigs, RMKless, AWegert, ARatcliffe, PJostock, RKoch, TLinz, KSchroeder, W 8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives US Patent  US10793556 Publication Date 10/6/2020 
Target
Name:
Mu-type opioid receptor
Synonyms:
M-OR-1 | MOP | MOR-1 | MOR1 | MUOR1 | Mu Opioid Receptor | Mu opiate receptor | OPIATE Mu | OPRM1 | OPRM_HUMAN | hMOP | mu-type opioid receptor isoform MOR-1
Type:
G Protein-Coupled Receptor (GPCR)
Mol. Mass.:
44789.51
Organism:
Homo sapiens (Human)
Description:
P35372
Residue:
400
Sequence:
MDSSAAPTNASNCTDALAYSSCSPAPSPGSWVNLSHLDGNLSDPCGPNRTDLGGRDSLCPPTGSPSMITAITIMALYSIVCVVGLFGNFLVMYVIVRYTKMKTATNIYIFNLALADALATSTLPFQSVNYLMGTWPFGTILCKIVISIDYYNMFTSIFTLCTMSVDRYIAVCHPVKALDFRTPRNAKIINVCNWILSSAIGLPVMFMATTKYRQGSIDCTLTFSHPTWYWENLLKICVFIFAFIMPVLIITVCYGLMILRLKSVRMLSGSKEKDRNLRRITRMVLVVVAVFIVCWTPIHIYVIIKALVTIPETTFQTVSWHFCIALGYTNSCLNPVLYAFLDENFKRCFREFCIPTSSNIEQQNSTRIRQNTRDHPSTANTVDRTNHQLENLEAETAPLP
  
Inhibitor
Name:
BDBM464586
Synonyms:
CIS-1-(Cyclobutyl-methyl)-8-dimethylamino-3-[2-(2-methoxy-ethoxy)-ethyl]-8- phenyl-1,3-diazaspiro[4.5]decan-2-one | US10793556, Example SC_4006
Type:
Small organic molecule
Emp. Form.:
C26H41N3O3
Mol. Mass.:
443.622
SMILES:
COCCOCCN1C[C@]2(CC[C@@](CC2)(N(C)C)c2ccccc2)N(CC2CCC2)C1=O |r,wU:12.15,9.25,(-6.73,-8.7,;-5.64,-9.78,;-4.16,-9.39,;-3.07,-10.47,;-1.58,-10.08,;-.49,-11.17,;1,-10.77,;2.09,-11.86,;3.55,-11.38,;4.46,-12.63,;5.23,-13.96,;6.77,-13.96,;7.54,-12.63,;6.77,-11.29,;5.23,-11.29,;8.62,-11.54,;10.11,-11.94,;8.23,-10.05,;8.62,-13.71,;8.23,-15.2,;9.32,-16.29,;10.8,-15.89,;11.2,-14.4,;10.11,-13.32,;3.55,-13.87,;4.03,-15.34,;3,-16.48,;1.51,-16.88,;1.91,-18.37,;3.4,-17.97,;2.09,-13.4,;.84,-14.3,)|
Structure:
Search PDB for entries with ligand similarity: